Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 199 results for "biotechnology regulatory authority of..."

Intl. Biotechnology Trust PLC Annual Financial Report - Replac...

TIDMIBT RNS Number : 9804V Intl. Biotechnology Trust PLC 03 November 2014 INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the "Company") Annual Financial Report Announcement of Audited Results for the year ended 31 August 2014 The following ... ADVFN UK, 2 weeks ago
Annual Financial Report - Replacement TrustNet, 2 weeks ago
Annual Financial Report TrustNet, 2 weeks ago

Half Yearly Report

Regulatory Story Scottish Mortgage Inv Tst PLC - SMT Released 07:00 07-Nov-2014 RNS Number : 4075W Scottish Mortgage Inv Tst PLC 07 November 2014  RNS Announcement Scottish Mortgage Investment Trust PLC Results for the half-year to 30 September ...
 London Stock Exchange2 weeks ago
EuroInvestor

REG-Sanofi : Shantha's Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India

Shantha's Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India - The live, oral, ready-to-use tetravalent rotavirus vaccine candidate is designed to protect young children from severe diarrhea - Lyon, France - October ...
 Reuters1 month ago Shantha's Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India  FierceVaccines1 month ago Sanofi : Shantha's Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India  EuroInvestor1 month ago SANOFI : : Shantha's Investigational Rotavirus Vaccine Enters Phase III Clinical Trials in India  4 Traders1 month ago
Times of India

No quality control for life-saving generic drugs, govt apathetic

NEW DELHI: While the Indian government is pushing generic drugs as they are cheaper and, therefore, more affordable, there seems to inadequate attention on ensuring that the quality protocol of these drugs is properly observed. A case in point is ...
 Times of India2 months ago

International Stem Cell Corporation Announces Record Revenues and Significant Progress in R

) - (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products today provided a business update and announced financial resultsfor the three and nine months ended September 30, 2014. ...
 Tamar Securities1 week ago
[x]  
Malaysian Insider

Animal scientists debate on ethical animal use

More than 320 delegates from as many as 22 countries participated at theAsian Federation of Laboratory Animal Science Associations'(Aflas) Congress last Monday. The two-day event which was attended by nations across the Asian, American and ...
 Malaysian Insider6 days ago

ABIVAX Signs Agreement With The To Commercialise Meningococcal And Typhoid Vaccines In Asia And Latin America

/PRNewswire/ -- ABIVAX, a leading European, clinical stage biopharmaceutical company developing and commercializing anti-viral compounds and human vaccines, today announced that it has signed an agreement with The Finlay Institute, Havana, Cuba, ...
 BioSpace1 week ago ABIVAX Signs Agreement With the Finlay Institute to Commercialise Meningococcal and Typhoid Vaccines in Asia and Latin America  TickerTech.com1 week ago
[x]  

The pCri System: A Vector Collection for Recombinant Protein Expression and Purification

Abstract A major bottleneck in structural, biochemical and biophysical studies of proteins is the need for large amounts of pure homogenous material, which is generally obtained by recombinant overexpression. Here we introduce a vector collection, ...
 Plosone.org1 week ago
CommodityOnline

How to stay positive when Gold falls 2% or more in a day?

Frank Holmes' advice to investors? Chill. In his interview with The Gold Report, the veteran commodities investor shared some strategies that help him "sit back and stay balanced," namely by diversifying and following the money. Find out about the ...
 CommodityOnline1 week ago

EPIRUS BIOPHARMACEUTICALS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations.

EPIRUS MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our financial statements ...
 Pharmacy Choice1 week ago NOVAVAX INC - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations  TMC Net2 weeks ago IMS HEALTH HOLDINGS, INC. - 10-Q - Management's Discussion and Analysis of Financial Condition and Results of Operations  TMC Net3 weeks ago CANCER GENETICS, INC - 10-Q/A - Management's Discussion and Analysis of Financial Condition and Results of Operations  TMC Net2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less